Summary
Date: 12 January 2018
Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2017 Measures No.1) Bill 2017 and the Therapeutic Goods (Charges) Amendment Bill 2017. Under these Bills, the TGA will introduce a list of permitted indications from which sponsors must exclusively draw when listing their medicine on the Australian Register of Therapeutic Goods (ARTG).
The RACGP is concerned that including numerous ‘traditional’ indications on this list encourages industry to evade the requirement to have scientific proof of efficacy for their products, endorses pseudoscience and will mislead and confuse consumers.